Lim Yoon Pin’s laboratory of Molecular and Translational Cancer Research

Patents/Inventions


Invention Disclosure Title: Plasma C9 Protein is a Potential Biomarker for Gastric Cancer Diagnosis (09115A)

No Patent Title Country File No Date Filed Patent Number Date Granted
1. Cancer Biomarker and Uses Thereof Singapore 200904976-8 23/07/2009
2. Cancer Biomarker And The Use Thereof PCT PCT/SG2010/000280 23/07/2010
3. Cancer Biomarker And The Use Thereof Singapore 201200372-9 17/01/2012 177702 15/04/2013
4. Cancer Biomarker and The Use Thereof United States 13/386,357 20/01/2012 8,669,067 11/03/2014
5. Cancer Biomarker And The Use Thereof European 10802526.3 31/01/2012
6. Plasma C9 Protein Is A Potential Biomarker For Gastric Cancer Diagnosis (Cancer Biomarker And Uses Thereof) China 2.0108E+11 22/03/2012 ZL201080042262.4 31/12/2014
7. Cancer Biomarker And The Use Thereof United Kingdom 10802526.3 23/10/2014 2457092 23/10/2014
8. Cancer Biomarker And The Use Thereof France 10802526.3 21/11/2014 2457092 21/11/2014
9. Cancer Biomarker And The Use Thereof Germany 10802526.3 11/12/2014 60 2010 019 742.5 11/12/2014

Invention Disclosure Title: ITIH3 for Detection of Gastric Cancer (10174N)
Other inventors: Shirly Poh Kuan CHONG

No Patent Title Country File No Date Filed Patent Number Date Granted
1. ITIH3 for Detection of Gastric Cancer United States 61/397,299 10/06/2010
2. Methods for Detection of Gastric Cancer United States 13/156,782 09/06/2011 9,562,906 07/02/2017

Invention Disclosure Title: WBP2 as a Drug Target and Biomarker for Cancer (10254A)

No Patent Title Country File No Date Filed Patent Number Date Granted
1. WBP2 As A Drug Target And Biomarker For Cancer Singapore 201006302-2 30/08/2010
2. Novel Cancer Target And Biomarker PCT PCT/SG2011/000293 25/08/2011
3. Tyrosine-Phosphorylated WBP2, A Novel Cancer Target and Biomarker United States 13/819,940 28/02/2013 9,429,582  30/08/2016
4. Novel Cancer Target And Biomarker Singapore 201301529-2 28/02/2013
5. Tyrosine-Phosphorylated WBP2, A Novel Cancer Target and Biomarker China 2.0118E+11 26/04/2013 ZL 201180051871.0 15/02/2017
6. Novel Cancer Target And Biomarker Singapore 10201508307S 07/10/2015
7. Tyrosine-Phosphorylated WBP2, a Novel Cancer Target and Biomarker United States 15/209,538 13/07/2016

Invention Disclosure Title: Discovery of Novel Breast Cancer Metastasis Effectors using Phosphoproteomics (11170A)

No Patent Title Country File No Date Filed Patent Number Date Granted
1. Discovery of Novel Breast Cancer Metastasis Effectors using Phosphoproteomics Singapore 201106166-0 25/08/2011
2. A Protein Involved in Detection of Cancer Metastasis and a Treatment thereof PCT PCT/SG2012/000301 24/08/2012
3. A Protein Involved in Detection of Cancer Metastasis and a Treatment thereof Singapore 11201400161S 24/02/2014
4. A Protein Involved in Detection of Cancer Metastasis and a Treatment thereof United States 14/240,798 25/02/2014 9,359,423 07/06/2016
5. A Protein Involved in Detection of Cancer Metastasis and a Treatment thereof European 12825069.3 26/02/2014

Invention Disclosure Title: ITCH is A Negative Regulator of WBP2 (14402A)

No Patent Title Country File No Date Filed Patent Number Date Granted
1. ITCH is A Negative Regulator of WBP2 Singapore 1020141785R 24/04/2014
2. Method For Predicting Response To Therapy For Cancer PCT PCT/SG2015/050085 24/04/2015
3. Method For Predicting Response To Therapy For Cancer Singapore 11201608328R 05/10/2016
4. Method For Predicting Response To Therapy For Cancer United States 15/305,905 21/10/2016

Invention Disclosure Title: WBP2: Biomarker For Gastric Cancer Detection And Therapy (15033N)

No Patent Title Country File No Date Filed Patent Number Date Granted
1. WBP2: Biomarker For Gastric Cancer Detection And Therapy United States 62/231,324 01/07/2015

Invention Disclosure Title: WBP2 As A Co-Prognostic Factor With Her2 For Stratification Of Patients For Herceptin Treatment (15234A)

No Patent Title Country File No Date Filed Patent Number Date Granted
1. WBP2 As Prognostic Factor With Her2 For Stratification Of Patients For Treatmen Singapore 10201505756X 23/07/2015
2. WBP2 as a Co-Prognostic Factor with Her2 for Stratification of Patients for Treatment PCT PCT/SG2016/050341 19/07/2016